ALGORITHMS SOFTWARE UK LIMITED

Financial Health Assessment: ALGORITHMS SOFTWARE UK LIMITED

1. Financial Health Score: C+ Explanation: The company has experienced a significant decline in financial health over the last year, moving from a position of robust strength to one of acute distress. While the business is not terminally ill—thanks to remaining cash reserves and parent company support—it is exhibiting symptoms of a severe "cash bleed" and profitability issues that require immediate intervention.

2. Key Vital Signs These are the core metrics that indicate the current physical state of the business:

• Net Assets (Equity): £358,349 (Down from £1,021,238 in 2024)
  • Interpretation: This is the company's "bone mass." It has weakened significantly, dropping by approximately 65% in one year. However, it remains positive, meaning the business still has value.
• Cash at Bank: £1,329,266 (Down from £2,082,081 in 2024)
  • Interpretation: The "hydration level." The company has spent over £750,000 in cash this year. While still holding a decent buffer, this rate of dehydration is alarming.
• Working Capital (Net Current Assets): £330,186 (Down from £1,007,702)
  • Interpretation: The "short-term stamina." The company's ability to cover its immediate bills has shrunk to a third of what it was. The current ratio is approximately 1.15, meaning it has £1.15 in short-term assets for every £1 of short-term liabilities. This is adequate but tight.
• Employee Headcount: 15 (Up from 9 in 2024)
  • Interpretation: The "metabolic rate." The company has increased its workforce by over 60%, which likely contributes to higher operational costs and the observed cash burn.
• Group Debt: £518,627
  • Interpretation: This is an interest-free loan from the parent company ("family transfusion"), repayable on demand. It provides flexibility but also represents a latent risk if the parent calls it in.

3. Symptoms Analysis What the numbers reveal about the underlying business health:

• Severe Profitability Shock: The Profit & Loss reserve dropped from £913,116 to £250,227. This indicates a loss of approximately £662,889 for the year ending March 2025. This is the primary "pathogen" affecting the company's health.
• Rising Accruals: Accruals and deferred income jumped from £1.18m to £1.39m. This suggests a build-up of obligations or deferred revenue that may complicate cash flow management.
• Increased Trade Creditors: Trade creditors rose from £20k to £52k. While small in absolute terms, this represents a 150% increase, suggesting the company may be stretching its payment terms with suppliers to conserve cash.

4. Diagnosis The patient is suffering from Acute Operational Cash Burn. The decision to expand the workforce appears to have outpaced revenue generation, leading to a significant loss for the year. This loss has consumed a large portion of the company's cash reserves and equity. The business is currently relying on a "life support" letter of support from its parent company, Algorithms Software Pvt Ltd, to maintain going concern status. While not insolvent, the company's immune system is compromised, making it vulnerable to further shocks.

5. Prognosis The short-term survival outlook is Stable but Guarded. The company has sufficient cash to survive the next 12 months, especially with parent company backing. However, if the underlying loss-making trend is not reversed in the current financial year, the cash reserves will be depleted rapidly. Within 18-24 months, without a return to profitability or further capital injections, the company could face insolvency.

6. Recommendations To restore financial wellness, the following "treatment plan" is recommended:

1. Stop the Bleeding (Cost Control): Immediately review the cost base, particularly the return on investment from the six new hires. If revenue has not scaled to support this headcount, difficult decisions regarding staffing may be necessary.
2. Improve Circulation (Cash Flow Management): Debtors stand at over £1.06m due within a year. Implement stricter credit control procedures to accelerate cash collection and improve liquidity.
3. Monitor the "Deferred" Build-up: Investigate the £1.39m in accruals and deferred income. Ensure this does not represent unrecognized costs that could further damage the P&L in future periods.
4. Formalize Family Support: While the parent company has provided a letter of support, consider formalizing the £518k group debt into a longer-term loan agreement to remove the "repayable on demand" risk from the balance sheet.